Welcome to Quotient Sciences - Nottingham, UK

Global Headquarters
Outside of one of Quotient Sciences' buildings in Nottingham, UK
Site Spotlight, Nottingham, Translational Pharmaceutics, Dr. Andrew Lewis

Spotlight on Nottingham

By: Clare Preskey & Dr. Andrew Lewis Read More

Meet our team

We help turn your molecules into medicines of the future, working as partners with a single goal of getting get new treatments to those in need, fast. Meet some of our team members who you'll see or work with when you have a project with us at Nottingham.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Stuart Mair

Global VP, Medical, Early Development

Dr. Stuart (Stu) Mair has over 16 years of experience delivering exploratory clinical studies in the contract research organizatio...

About Stuart
John McDermott

Vice President, Scientific Consulting

John McDermott is Vice President of Scientific Consulting at Quotient Sciences. John leads Quotient Sciences' global drug developm...

About John
Dr. Andrew Parker

Senior Drug Development Consultant

Dr. Andrew Parker has two decades of experience in the pharmaceutical industry, spanning from preclinical development, through ear...

About Andrew
Nazim Kanji

Executive Director, Pediatric Services

Nazim Kanji is the Executive Director of Pediatric Services at Quotient Sciences. In his current role, Nazim works closely with cl...

About Nazim
Dr. Alyson Connor

Executive Director, Strategic Partnerships, Clinical Pharmacology

Over 25 years’ experience in the design and conduct of early phase clinical programs, with particular emphasis on the use of adapt...

About Alyson

News from Quotient Sciences - Nottingham

More News
Translational Pharmaceutics®, Martin Wing-King Leveraging Simplicity to Enhance Efficiency for First-in-human Clinical Trials By: Martin Wing-King
Read Now
News & Announcements, Customer Milestone, Translational Pharmaceutics® Oxilio completes first clinical trial with OXL001 at Quotient Sciences - Nottingham
Read Now
Get in touch
Humanity can't afford to wait, so neither can we.